CYTOO's News
Join us on LinkedIn
Discover our latest articles
🎯 Kidney toxicity: the #1 cause of drug candidate failure in late-stage development
What if you could predict nephrotoxicity earlier, with a model that actually mimics in vivo physiology?
Imaging mitochondria without artifacts? 🔋
Staining and imaging the highly connected mitochondrial network is difficult, and artifacts are common.
At CYTOO, we have the
🔬 Turn Your Cell Images Into Powerful Therapeutic Insights with AI-Powered Phenotyping
Behind every microscopy image lies a wealth of information about cellular treatment response.
🔬 Monitoring lipid accumulation in muscle cells with imaging
An imaging-based approach to monitor fatty acid uptake and lipid accumulation in vitro provides spatially resolved, quantitative, and dynamic data
🚀 Powering Precision: Functional Potency Assays by CYTOO
CYTOO develops functional potency assays to ensure batch consistency, biological activity, and regulatory compliance for gene therapies and biologics.
Revolutionizing Target Validation with Disease-Relevant Cellular Models
What’s the risk of using cellular models that lack disease-specific pathways for target validation❓